CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenue:
Total net revenue	$ 261,016	$ 261,004	$ 217,217
Operating expenses:
Research and development	0	0	1,355
General and administrative	14,656	20,053	32,258
General and administrative - related party	0	2,700	0
Total operating expenses	14,656	22,753	33,613
Income from operations	246,360	238,251	183,604
Other expense, net	(345)	(5,702)	(7,038)
Interest income	5,540	1,660	1,311
Interest expense	(18,660)	(23,954)	(43,601)
Income before income taxes	232,895	210,255	134,276
Income tax benefit (expense), net	41,902	(196,073)	4
Net income	190,993	406,328	134,272
Net income attributable to noncontrolling interest	33,705	11,272	129
Net income attributable to Innoviva stockholders	$ 157,288	$ 395,056	$ 134,143
Basic net income per share attributable to Innoviva stockholders	$ 1.55	$ 3.92	$ 1.25
Diluted net income per share attributable to Innoviva stockholders	$ 1.43	$ 3.53	$ 1.17
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	101,150	100,849	106,945
Shares used to compute diluted net income per share	113,409	113,408	119,866
Royalty revenue from a related party
Revenue:
Total net revenue	$ 261,016	$ 261,004	$ 214,118
Revenue from collaborative arrangements from a related party
Revenue:
Total net revenue	$ 0	$ 0	$ 3,099